Alpha-1 Antitrypsin Deficiency: How to Spot and Treat It
This inherited condition can increase your patients’ risk of lung and liver disease.
Category: Pulmonology
Lung Disease Patients Benefit from Robot-Assisted Procedures
Advances in minimally invasive surgical approaches mean smaller incisions, less bleeding and faster recoveries.
Lung Disease: What You Need to Know to Breathe Easy
Your essential guide to symptoms, risk and prevention.
3 Habits for Healthy Lungs
Reduce your risk of lung disease, including cancer and COPD.
Snoring vs. Sleep Apnea – Is There a Difference?
Quiz yourself to find out if your night noises could indicate sleep apnea, a potentially dangerous condition
UNC lung researchers awarded $12.5-million NIH grant to develop new...
The National Institutes of Health has awarded four UNC experts a translational program project grant (tPPG) to develop and test therapeutics aimed at reducing the hyper-concentration of mucus often found in cystic fibrosis and asthma patients.
Asthma, Cystic Fibrosis, Grants, Innovation, News, Pulmonology
Can E-cigarettes help COPD patients quit smoking and reduce harm to...
Using data from two studies on COPD, researchers at the UNC School of Medicine are trying to understand the effects of e-cigarettes on use patterns and whether they can mitigate the worst health outcomes of COPD. Initial results of a preliminary study do not reflect positively on e-cigarettes.
Chronic Bronchitis: New Insights Could Lead to First Diagnostic Tes...
A New England Journal of Medicine study describes how airway dehydration makes mucus thick—the hallmark of chronic bronchitis, the precursor to deadly COPD.
Scientists create stem cell therapy for lung fibrosis conditions
Through a joint UNC School of Medicine-NC State research project shows how to harvest lung stem cells non-invasively and then multiply healthy cells – a potentially powerful therapy against inflammatory lung conditions.
COPD, Cystic Fibrosis, News, Publications, Pulmonology, Research
UNC lung researchers team with Durham biotech Parion for $7.7 milli...
The partnership aims to create new drugs to help patients with lung diseases clear mucus, a major roadblock to normal respiratory health.
UNC researchers find genetic trigger for RSV-induced infant hospita...
The discovery could lead to new therapies and better diagnostics, resulting in fewer hospitalizations of children with respiratory syncytial virus, the leading cause of severe lung infection in babies.
Newly approved blood thinner may increase susceptibility to some vi...
A study led by UNC researchers indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis.